{"transactions":[{"id":741781,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:41:11.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-267732","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000119312526267732/ownership.xml","form_type":"4"}},{"id":741221,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:20:52.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":37000,"derivative":{"exercise_price":2.46,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001193125-26-267601","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000119312526267601/ownership.xml","form_type":"4"}},{"id":744665,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:09:19.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264390/ownership.xml","form_type":"4"}},{"id":784882,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Warrants (Right to Buy)","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"other","planned":false,"acquired":false,"shares":764312,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 12"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.1,"underlying":"Common Stock","underlying_shares":78656},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":36,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784881,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":2657860,"ownership":{"direct":false,"nature":"See Note 12"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":273527},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":35,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784880,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":4500000,"ownership":{"direct":false,"nature":"See Note 12"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":463106},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":34,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784879,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Warrants (Right to Buy)","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"other","planned":false,"acquired":false,"shares":484395,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.1,"underlying":"Common Stock","underlying_shares":49850},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":33,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784878,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":1614650,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":166168},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":32,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784877,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":200000,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20582},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784876,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":1899984,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":204658},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784875,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":2374981,"ownership":{"direct":false,"nature":"See Note 9"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities are directly held by SR One Co-Invest IV, LLC (\"SR One Co-Invest IV\"). SR One Co-Invest IV Manager, LLC (\"SR One Co-Invest Manager\") is the managing member of SR One-Co-Invest IV, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":255823},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784874,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":1151580,"ownership":{"direct":false,"nature":"See Note 9"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities are directly held by SR One Co-Invest IV, LLC (\"SR One Co-Invest IV\"). SR One Co-Invest IV Manager, LLC (\"SR One Co-Invest Manager\") is the managing member of SR One-Co-Invest IV, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":118512},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784873,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Warrants (Right to Buy)","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"other","planned":false,"acquired":false,"shares":1861211,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.1,"underlying":"Common Stock","underlying_shares":191541},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784872,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":6644650,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":683817},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784871,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":600142,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":61762},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784870,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":544162,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":59692},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784869,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":1299842,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A-2 Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.3268 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series A-2 Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.3268 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A-2 Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.3268 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-2 Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.3268 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":139366},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784868,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":4606320,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":474048},"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784867,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":18,"value":3600000.0,"ownership":{"direct":false,"nature":"See Note 12"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1014851,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784866,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":438,"price":18,"value":7884.0,"ownership":{"direct":false,"nature":"See Note 12"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"shares","element":"transactionShares","label":"F13","text":"Pursuant to the terms of the warrants, the Issuer withheld 438 warrant shares to pay the exercise price in connection with the net exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":814851,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784865,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"other","planned":false,"acquired":true,"shares":78656,"ownership":{"direct":false,"nature":"See Note 12"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":815289,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784864,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":273527,"ownership":{"direct":false,"nature":"See Note 12"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":736633,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784863,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":463106,"ownership":{"direct":false,"nature":"See Note 12"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":463106,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784862,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":133333,"price":18,"value":2399994.0,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":574314,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784861,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":277,"price":18,"value":4986.0,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"shares","element":"transactionShares","label":"F11","text":"Pursuant to the terms of the warrants, the Issuer withheld 277 warrant shares to pay the exercise price in connection with the net exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":440981,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784860,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"other","planned":false,"acquired":true,"shares":49850,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":441258,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784859,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":166168,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":391408,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784858,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":20582,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":225240,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784857,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":204658,"ownership":{"direct":false,"nature":"See Note 10"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities are directly held by SR One Co-Invest IV-A, LLC (\"SR One Co-Invest IV-A\"). SR One Co-Invest IV Manager is the managing member of SR One-Co-Invest IV-A, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":204658,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784856,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":255823,"ownership":{"direct":false,"nature":"See Note 9"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities are directly held by SR One Co-Invest IV, LLC (\"SR One Co-Invest IV\"). SR One Co-Invest IV Manager, LLC (\"SR One Co-Invest Manager\") is the managing member of SR One-Co-Invest IV, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":374335,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784855,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":118512,"ownership":{"direct":false,"nature":"See Note 9"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The securities are directly held by SR One Co-Invest IV, LLC (\"SR One Co-Invest IV\"). SR One Co-Invest IV Manager, LLC (\"SR One Co-Invest Manager\") is the managing member of SR One-Co-Invest IV, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":118512,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784854,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":222222,"price":18,"value":3999996.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1831383,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784853,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":1065,"price":18,"value":19170.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"shares","element":"transactionShares","label":"F8","text":"Pursuant to the terms of the warrants, the Issuer withheld 1,065 warrant shares to pay the exercise price in connection with the net exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1609161,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784852,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"other","planned":false,"acquired":true,"shares":191541,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1610226,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784851,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":683817,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1418685,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784850,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":61762,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":734868,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784849,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":59692,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":673106,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784848,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":139366,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series A-2 Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.3268 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":613414,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":784847,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:11:42.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":474048,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":474048,"source":{"system":"sec-edgar","filing":"0001193125-26-217656","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526217656/ownership.xml","form_type":"4"}},{"id":795806,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":9418560,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":489486},"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":795805,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Convertible Preferred Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":6827429,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":354824},"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":795804,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":9418561,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund II Aggregator, LP (\"SR One Fund II Aggregator\"). SR One Capital Partners II, LP (\"SR One Partners II\") is the general partner of SR One Fund II, and SR One Capital Management, LLC (\"SR One Capital Management\") is the general partner of SR One Partners II. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Partners II, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":489486},"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":795803,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Convertible Preferred Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":27309719,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund II Aggregator, LP (\"SR One Fund II Aggregator\"). SR One Capital Partners II, LP (\"SR One Partners II\") is the general partner of SR One Fund II, and SR One Capital Management, LLC (\"SR One Capital Management\") is the general partner of SR One Partners II. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Partners II, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1419298},"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":795802,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"purchase","planned":false,"acquired":true,"shares":277777,"price":18,"value":4999986.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1122087,"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":795801,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":489486,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":844310,"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":795800,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":354824,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by AMZL, LP (\"AMZL\"). SR One Capital SMA Partners, LP (\"SR One SMA Partners\") is the general partner of AMZL, and SR One Capital Management is the general partner of SR One SMA Partners. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One SMA Partners, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":354824,"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":795799,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"purchase","planned":false,"acquired":true,"shares":277778,"price":18,"value":5000004.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund II Aggregator, LP (\"SR One Fund II Aggregator\"). SR One Capital Partners II, LP (\"SR One Partners II\") is the general partner of SR One Fund II, and SR One Capital Management, LLC (\"SR One Capital Management\") is the general partner of SR One Partners II. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Partners II, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":2186562,"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":795798,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":489486,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 1, 2026, each share of Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund II Aggregator, LP (\"SR One Fund II Aggregator\"). SR One Capital Partners II, LP (\"SR One Partners II\") is the general partner of SR One Fund II, and SR One Capital Management, LLC (\"SR One Capital Management\") is the general partner of SR One Partners II. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Partners II, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1908784,"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":795797,"issuer":{"id":4662,"kind":"organization","name":"Avalyn Pharma Inc.","symbol":"AVLN"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T22:46:03.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":1419298,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 1, 2026, each share of Series C-1 Convertible Preferred Stock (the \"Series C-1 Preferred Stock\") automatically converted into shares of Common Stock on a one-for-19.2417 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund II Aggregator, LP (\"SR One Fund II Aggregator\"). SR One Capital Partners II, LP (\"SR One Partners II\") is the general partner of SR One Fund II, and SR One Capital Management, LLC (\"SR One Capital Management\") is the general partner of SR One Partners II. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Partners II, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1419298,"source":{"system":"sec-edgar","filing":"0001193125-26-201887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312526201887/ownership.xml","form_type":"4"}},{"id":1019347,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T21:14:56.000Z","date":"2025-10-09","kind":"purchase","planned":false,"acquired":true,"shares":63157,"price":19,"value":1199983.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired from the Issuer on October 9, 2025 pursuant to a Securities Purchase Agreement dated October 7, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held directly by AMZL, LP. SR One Capital SMA Partners, LP is the general partner of AMZL, LP, and SR One Capital Management, LLC is the general partner of SR One Capital SMA Partners, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital SMA Partners, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1917895,"source":{"system":"sec-edgar","filing":"0001193125-25-239153","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312525239153/ownership.xml","form_type":"4"}},{"id":1019346,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T21:14:56.000Z","date":"2025-10-09","kind":"purchase","planned":false,"acquired":true,"shares":63158,"price":19,"value":1200002.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired from the Issuer on October 9, 2025 pursuant to a Securities Purchase Agreement dated October 7, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Opportunities Fund I, LP. SR One Capital Opportunities Partners I, LP is the general partner of SR One Capital Opportunities Fund I, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Opportunities Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Opportunities Partners I, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1173395,"source":{"system":"sec-edgar","filing":"0001193125-25-239153","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000119312525239153/ownership.xml","form_type":"4"}},{"id":1085539,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-17T21:19:13.000Z","date":"2025-07-16","kind":"purchase","planned":false,"acquired":true,"shares":960983,"price":52.03,"value":49999945.49,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital SMA Partners, LP (\"SMA Partners\"). SMA Partners is the sole general partner of AMZL, LP (\"AMZL\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by AMZL in which the Reporting Person has no pecuniary interest."}],"balance_after":1730179,"source":{"system":"sec-edgar","filing":"0000950170-25-096666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025096666/ownership.xml","form_type":"4"}},{"id":1085538,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-17T21:19:13.000Z","date":"2025-07-16","kind":"purchase","planned":false,"acquired":true,"shares":22319,"price":52.03,"value":1161257.57,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital Opportunities Partners I, LP (\"SR One Opportunities Partners I\"). SR One Opportunities Partners I is the sole general partner of SR One Capital Opportunities Fund I, LP (\"SR One Opportunities Fund I\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Opportunities Fund I in which the Reporting Person has no pecuniary interest."}],"balance_after":238897,"source":{"system":"sec-edgar","filing":"0000950170-25-096666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025096666/ownership.xml","form_type":"4"}},{"id":1085537,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-17T21:19:13.000Z","date":"2025-07-16","kind":"purchase","planned":false,"acquired":true,"shares":6510,"price":52.03,"value":338715.3,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the sole managing member of SR One Capital Management, LLC (\"SR One Capital Management\"), which is the sole general partner of SR One Capital Partners II, LP (\"SR One Partners II\"). SR One Partners II is the sole general partner of SR One Capital Fund II Aggregator, LP (\"SR One Fund II Aggregator\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the securities held by SR One Fund II Aggregator in which the Reporting Person has no pecuniary interest."}],"balance_after":69687,"source":{"system":"sec-edgar","filing":"0000950170-25-096666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025096666/ownership.xml","form_type":"4"}},{"id":1113584,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:48:21.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 10, 2025 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":4.01,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0000950170-25-085506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000095017025085506/ownership.xml","form_type":"4"}},{"id":1117419,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:39:15.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 5, 2026 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":46000,"derivative":{"exercise_price":1.83,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0000950170-25-083803","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000095017025083803/ownership.xml","form_type":"4"}},{"id":1119668,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:47:02.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":38.57,"expiration_date":"2035-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000950170-25-083298","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025083298/ownership.xml","form_type":"4"}},{"id":1406750,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-09-17T00:51:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":5809528,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by SR One Capital Opportunities Fund I, LP. SR One Capital Opportunities Partners I, LP is the general partner of SR One Capital Opportunities Fund I, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Opportunities Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Opportunities Partners I, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":669061},"source":{"system":"sec-edgar","filing":"0000950170-24-106978","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000095017024106978/ownership.xml","form_type":"4"}},{"id":1406749,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-09-17T00:51:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":4357146,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held directly by AMZL, LP. SR One Capital SMA Partners, LP is the general partner of AMZL, LP, and SR One Capital Management, LLC is the general partner of SR One Capital SMA Partners, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital SMA Partners, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":501796},"source":{"system":"sec-edgar","filing":"0000950170-24-106978","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000095017024106978/ownership.xml","form_type":"4"}},{"id":1406748,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-09-17T00:51:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":13071439,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund II Aggregator, LP. SR One Capital Partners II, LP is the general partner of SR One Capital Fund II Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners II, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners II, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1505388},"source":{"system":"sec-edgar","filing":"0000950170-24-106978","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000095017024106978/ownership.xml","form_type":"4"}},{"id":1406747,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:51:38.000Z","date":"2024-09-16","kind":"purchase","planned":false,"acquired":true,"shares":441176,"price":17,"value":7499992.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by SR One Capital Opportunities Fund I, LP. SR One Capital Opportunities Partners I, LP is the general partner of SR One Capital Opportunities Fund I, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Opportunities Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Opportunities Partners I, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1110237,"source":{"system":"sec-edgar","filing":"0000950170-24-106978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000095017024106978/ownership.xml","form_type":"4"}},{"id":1406746,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:51:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":669061,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by SR One Capital Opportunities Fund I, LP. SR One Capital Opportunities Partners I, LP is the general partner of SR One Capital Opportunities Fund I, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Opportunities Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Opportunities Partners I, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":669061,"source":{"system":"sec-edgar","filing":"0000950170-24-106978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000095017024106978/ownership.xml","form_type":"4"}},{"id":1406745,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:51:38.000Z","date":"2024-09-16","kind":"purchase","planned":false,"acquired":true,"shares":1352942,"price":17,"value":23000014.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held directly by AMZL, LP. SR One Capital SMA Partners, LP is the general partner of AMZL, LP, and SR One Capital Management, LLC is the general partner of SR One Capital SMA Partners, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital SMA Partners, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1854738,"source":{"system":"sec-edgar","filing":"0000950170-24-106978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000095017024106978/ownership.xml","form_type":"4"}},{"id":1406744,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:51:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":501796,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held directly by AMZL, LP. SR One Capital SMA Partners, LP is the general partner of AMZL, LP, and SR One Capital Management, LLC is the general partner of SR One Capital SMA Partners, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital SMA Partners, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":501796,"source":{"system":"sec-edgar","filing":"0000950170-24-106978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000095017024106978/ownership.xml","form_type":"4"}},{"id":1406743,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:51:38.000Z","date":"2024-09-16","kind":"purchase","planned":false,"acquired":true,"shares":441176,"price":17,"value":7499992.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund II Aggregator, LP. SR One Capital Partners II, LP is the general partner of SR One Capital Fund II Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners II, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners II, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1946564,"source":{"system":"sec-edgar","filing":"0000950170-24-106978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000095017024106978/ownership.xml","form_type":"4"}},{"id":1406742,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":2,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:51:38.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":1505388,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund II Aggregator, LP. SR One Capital Partners II, LP is the general partner of SR One Capital Fund II Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners II, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners II, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":1505388,"source":{"system":"sec-edgar","filing":"0000950170-24-106978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000095017024106978/ownership.xml","form_type":"4"}},{"id":1477401,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T21:06:32.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":3.82,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0000950170-24-074363","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000095017024074363/ownership.xml","form_type":"4"}},{"id":1478488,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:30:14.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 13, 2025 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":22500,"derivative":{"exercise_price":6.23,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-24-073730","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000095017024073730/ownership.xml","form_type":"4"}},{"id":1496688,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-31T20:50:29.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on May 31, 2024 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":54.06,"expiration_date":"2034-05-30","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000950170-24-067402","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024067402/ownership.xml","form_type":"4"}},{"id":1558208,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-28T20:30:06.000Z","date":"2024-03-27","kind":"purchase","planned":false,"acquired":true,"shares":451659,"price":10,"value":4516590.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reports the purchase of shares in the underwritten public offering of common stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital Partners II, LP (\"SR One Partners II\"). SR One Partners II is the sole general partner of SR One Capital Fund II Aggregator, LP (\"SR One Fund II Aggregator\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the securities held by SR One Fund II Aggregator in which the Reporting Person has no pecuniary interest."}],"balance_after":451659,"source":{"system":"sec-edgar","filing":"0000950170-24-038089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000095017024038089/ownership.xml","form_type":"4"}},{"id":1558207,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-28T20:30:06.000Z","date":"2024-03-27","kind":"purchase","planned":false,"acquired":true,"shares":1548341,"price":10,"value":15483410.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reports the purchase of shares in the underwritten public offering of common stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the sole managing member of SR One Capital Management, LLC (\"SR One Capital Management\"), which is the sole general partner of SR One Capital Opportunities Partners I, LP (\"SR One Opportunities Partners I\"). SR One Opportunities Partners I is the sole general partner of SR One Capital Opportunities Fund I, LP (\"SR One Opportunities Fund I\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Opportunities Fund I in which the Reporting Person has no pecuniary interest."}],"balance_after":1548341,"source":{"system":"sec-edgar","filing":"0000950170-24-038089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000095017024038089/ownership.xml","form_type":"4"}},{"id":1615877,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-02-27T23:39:31.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":769196,"price":71.5,"value":54997514.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital SMA Partners, LP (\"SMA Partners\"). SMA Partners is the sole general partner of AMZL, LP (\"AMZL\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by AMZL in which the Reporting Person has no pecuniary interest."}],"balance_after":769196,"source":{"system":"sec-edgar","filing":"0000950170-24-021510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024021510/ownership.xml","form_type":"4"}},{"id":1615876,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-02-27T23:39:31.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":216578,"price":71.5,"value":15485327.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital Opportunities Partners I, LP (\"SR One Opportunities Partners I\"). SR One Opportunities Partners I is the sole general partner of SR One Capital Opportunities Fund I, LP (\"SR One Opportunities Fund I\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Opportunities Fund I in which the Reporting Person has no pecuniary interest."}],"balance_after":216578,"source":{"system":"sec-edgar","filing":"0000950170-24-021510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024021510/ownership.xml","form_type":"4"}},{"id":1615875,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-02-27T23:39:31.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":63177,"price":71.5,"value":4517155.5,"ownership":{"direct":false,"nature":"See Note 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the sole managing member of SR One Capital Management, LLC (\"SR One Capital Management\"), which is the sole general partner of SR One Capital Partners II, LP (\"SR One Partners II\"). SR One Partners II is the sole general partner of SR One Capital Fund II Aggregator, LP (\"SR One Fund II Aggregator\"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the securities held by SR One Fund II Aggregator in which the Reporting Person has no pecuniary interest."}],"balance_after":63177,"source":{"system":"sec-edgar","filing":"0000950170-24-021510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024021510/ownership.xml","form_type":"4"}},{"id":1728093,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":2,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":3,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107922,"kind":"organization","name":"SR One Co-Invest I, LLC","position":4,"cik":"0001864915","reported_name":"SR One Co-Invest I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107923,"kind":"organization","name":"SR One Co-Invest I Manager, LLC","position":5,"cik":"0001881204","reported_name":"SR One Co-Invest I Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":6,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-29T17:07:06.000Z","date":"2023-11-27","kind":"sale","planned":false,"acquired":false,"shares":178585,"price":0.6065,"value":108311.8025,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.5691 to $0.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by SR One Co-Invest I, LLC (\"SR One Co-Invest I\"). SR One Co-Invest I Manager, LLC (\"SR One Co-Invest I Manager\") is the managing member of SR One Co-Invest I and SR One Capital Management is the managing member of SR One Co-Invest I Manager. Dr. George is the managing member of SR One Capital Management (SR One Co-Invest I Manager, SR One Capital Management, and Dr. George together, the \"Co-Invest I Indirect Reporting Persons\"). The Co-Invest I Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Co-Invest I in which the Co-Invest I Indirect Reporting Persons have no pecuniary interest."}],"balance_after":1821415,"source":{"system":"sec-edgar","filing":"0001209191-23-056920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864915/000120919123056920/doc4.xml","form_type":"4"}},{"id":1728092,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":2,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":3,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107922,"kind":"organization","name":"SR One Co-Invest I, LLC","position":4,"cik":"0001864915","reported_name":"SR One Co-Invest I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107923,"kind":"organization","name":"SR One Co-Invest I Manager, LLC","position":5,"cik":"0001881204","reported_name":"SR One Co-Invest I Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":6,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-29T17:07:06.000Z","date":"2023-11-27","kind":"sale","planned":false,"acquired":false,"shares":430578,"price":0.6065,"value":261145.557,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.5691 to $0.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management (SR One Partners I, SR One Capital Management, and Dr. George together, the \"Fund I Indirect Reporting Persons\"). The Fund I Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the securities held by SR One Fund I Aggregator in which the Fund I Indirect Reporting Persons have no pecuniary interest."}],"balance_after":4391536,"source":{"system":"sec-edgar","filing":"0001209191-23-056920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864915/000120919123056920/doc4.xml","form_type":"4"}},{"id":1860534,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T21:56:00.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":62.59,"expiration_date":"2033-06-08","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-23-035992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123035992/doc4.xml","form_type":"4"}},{"id":1860062,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T21:42:19.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 7, 2024 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":22500,"derivative":{"exercise_price":4.86,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-23-035987","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000120919123035987/doc4.xml","form_type":"4"}},{"id":1870165,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:48:21.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following May 31, 2023 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.63,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-033847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123033847/doc4.xml","form_type":"4"}},{"id":1893690,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":2,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":3,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":4,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113514,"kind":"organization","name":"SR One Co-Invest II, LLC","position":5,"cik":"0001867644","reported_name":"SR One Co-Invest II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113515,"kind":"organization","name":"SR One Co-Invest II Manager, LLC","position":6,"cik":"0001910324","reported_name":"SR One Co-Invest II Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T22:16:52.000Z","date":"2023-05-11","kind":"sale","planned":false,"acquired":false,"shares":3804,"price":46.15,"value":175554.6,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by SR One Co-Invest II, LLC (\"SR One Co-Invest II\"). SR One Co-Invest II Manager, LLC (\"SR One Co-Invest II Manager\") is the managing member of SR One Co-Invest II and SR One Capital Management is the managing member of SR One Co-Invest II Manager. Dr. George is the managing member of SR One Capital Management (SR One Co-Invest II Manager, SR One Capital Management, and Dr. George together, the \"Co-Invest II Indirect Reporting Persons\"). The Co-Invest II Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Co-Invest II in which the Co-Invest II Indirect Reporting Persons have no pecuniary interest."}],"balance_after":1658780,"source":{"system":"sec-edgar","filing":"0001209191-23-029610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919123029610/doc4.xml","form_type":"4"}},{"id":1893689,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":2,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":3,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":4,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113514,"kind":"organization","name":"SR One Co-Invest II, LLC","position":5,"cik":"0001867644","reported_name":"SR One Co-Invest II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113515,"kind":"organization","name":"SR One Co-Invest II Manager, LLC","position":6,"cik":"0001910324","reported_name":"SR One Co-Invest II Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T22:16:52.000Z","date":"2023-05-11","kind":"sale","planned":false,"acquired":false,"shares":6485,"price":46.15,"value":299282.75,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management (SR One Partners I, SR One Capital Management, and Dr. George together, the \"Fund I Indirect Reporting Persons\"). The Fund I Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the securities held by SR One Fund I Aggregator in which the Fund I Indirect Reporting Persons have no pecuniary interest."}],"balance_after":2828394,"source":{"system":"sec-edgar","filing":"0001209191-23-029610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919123029610/doc4.xml","form_type":"4"}},{"id":1893688,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":2,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":3,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":4,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113514,"kind":"organization","name":"SR One Co-Invest II, LLC","position":5,"cik":"0001867644","reported_name":"SR One Co-Invest II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113515,"kind":"organization","name":"SR One Co-Invest II Manager, LLC","position":6,"cik":"0001910324","reported_name":"SR One Co-Invest II Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T22:16:52.000Z","date":"2023-05-11","kind":"sale","planned":false,"acquired":false,"shares":370612,"price":45,"value":16677540.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.745 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by SR One Co-Invest II, LLC (\"SR One Co-Invest II\"). SR One Co-Invest II Manager, LLC (\"SR One Co-Invest II Manager\") is the managing member of SR One Co-Invest II and SR One Capital Management is the managing member of SR One Co-Invest II Manager. Dr. George is the managing member of SR One Capital Management (SR One Co-Invest II Manager, SR One Capital Management, and Dr. George together, the \"Co-Invest II Indirect Reporting Persons\"). The Co-Invest II Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Co-Invest II in which the Co-Invest II Indirect Reporting Persons have no pecuniary interest."}],"balance_after":1662584,"source":{"system":"sec-edgar","filing":"0001209191-23-029610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919123029610/doc4.xml","form_type":"4"}},{"id":1893687,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":2,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":3,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":4,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113514,"kind":"organization","name":"SR One Co-Invest II, LLC","position":5,"cik":"0001867644","reported_name":"SR One Co-Invest II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113515,"kind":"organization","name":"SR One Co-Invest II Manager, LLC","position":6,"cik":"0001910324","reported_name":"SR One Co-Invest II Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T22:16:52.000Z","date":"2023-05-11","kind":"sale","planned":false,"acquired":false,"shares":631932,"price":45,"value":28436940.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.745 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"). SR One Capital Partners I, LP (\"SR One Partners I\") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC (\"SR One Capital Management\") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management (SR One Partners I, SR One Capital Management, and Dr. George together, the \"Fund I Indirect Reporting Persons\"). The Fund I Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the securities held by SR One Fund I Aggregator in which the Fund I Indirect Reporting Persons have no pecuniary interest."}],"balance_after":2834879,"source":{"system":"sec-edgar","filing":"0001209191-23-029610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919123029610/doc4.xml","form_type":"4"}},{"id":2079932,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T23:45:07.000Z","date":"2022-12-20","kind":"purchase","acquired":true,"shares":40000,"price":8.1358,"value":325432.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.86 to $8.45 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the managing member of SR One Capital Management, LLC (\"SR One Capital Management\"), which is the sole general partner of SR One Capital Partners I, LP (\"SR One Partners I\"). SR One Partners I is the sole general partner of SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the SR One Fund I Aggregator securities in which the Reporting Person has no pecuniary interest, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes."}],"balance_after":6526476,"source":{"system":"sec-edgar","filing":"0001209191-22-062227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062227/doc4.xml","form_type":"4"}},{"id":2079931,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T23:45:07.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":360000,"price":8.6336,"value":3108096.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.25 to $8.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the managing member of SR One Capital Management, LLC (\"SR One Capital Management\"), which is the sole general partner of SR One Capital Partners I, LP (\"SR One Partners I\"). SR One Partners I is the sole general partner of SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the SR One Fund I Aggregator securities in which the Reporting Person has no pecuniary interest, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes."}],"balance_after":6486476,"source":{"system":"sec-edgar","filing":"0001209191-22-062227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062227/doc4.xml","form_type":"4"}},{"id":2079930,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T23:45:07.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":500000,"price":8.2811,"value":4140550.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the managing member of SR One Capital Management, LLC (\"SR One Capital Management\"), which is the sole general partner of SR One Capital Partners I, LP (\"SR One Partners I\"). SR One Partners I is the sole general partner of SR One Capital Fund I Aggregator, LP (\"SR One Fund I Aggregator\"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (\"Section 16\"), or otherwise of such portion of the SR One Fund I Aggregator securities in which the Reporting Person has no pecuniary interest, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purposes."}],"balance_after":6126476,"source":{"system":"sec-edgar","filing":"0001209191-22-062227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122062227/doc4.xml","form_type":"4"}},{"id":2180680,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-17T20:40:00.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":8500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."}],"balance_after":0,"derivative":{"exercise_price":65.64,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-22-046285","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000120919122046285/doc4.xml","form_type":"4"}},{"id":2180679,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-17T20:40:00.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":8500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."}],"balance_after":0,"derivative":{"exercise_price":65.39,"expiration_date":"2030-06-14","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-22-046285","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000120919122046285/doc4.xml","form_type":"4"}},{"id":2180678,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-17T20:40:00.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."}],"balance_after":0,"derivative":{"exercise_price":27.06,"expiration_date":"2029-04-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-046285","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000120919122046285/doc4.xml","form_type":"4"}},{"id":2180677,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:40:00.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":2253660,"price":76,"value":171278160.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 2, 2022, by and among Turning Point Therapeutics, Inc. (the \"Issuer\"), Bristol-Myers Squibb Company (\"BMS\") and Rhumba Merger Sub Inc., a wholly owned subsidiary of BMS (\"Purchaser\"), on August 17, 2022, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of BMS (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for $76.00 per Share in cash, without interest, subject to any applicable withholding of taxes (the \"Cash Amount\"). Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the Cash Amount."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc, is the record holder of these shares reported herein. Simeon J. George is the Chief Executive Officer, President and a Member of the Board of Trustees at S.R. One, Limited and an employee of GlaxoSmithKline LLC, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc. Mr. George disclaims beneficial ownership of all shares held by S.R. One, Limited and this report shall not be deemed an admission of beneficial ownership of such shares for the purpose of Section 16 or for any other purpose except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-046285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000120919122046285/doc4.xml","form_type":"4"}},{"id":2230091,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:07:56.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":13.69,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122037511/doc4.xml","form_type":"4"}},{"id":2235956,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T21:39:55.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders."}],"balance_after":12000,"derivative":{"exercise_price":71.7,"expiration_date":"2032-06-09","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-036042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122036042/doc4.xml","form_type":"4"}},{"id":2235404,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:07:06.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares subject to the option vest 100% on the first to occur of (i) June 8, 2023 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":16000,"derivative":{"exercise_price":14.95,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-22-035822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000120919122035822/doc4.xml","form_type":"4"}},{"id":2287551,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T20:27:23.000Z","date":"2022-04-28","kind":"purchase","acquired":true,"shares":666666,"price":15,"value":9999990.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"SR One Co-Invest X, LLC purchased 666,666 shares of common stock of the issuer in connection with the issuer's public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by SR One Co-Invest X, LLC. SR One Co-Invest Manager X, LLC is the managing member of SR One Co-Invest X, LLC, and SR One Capital Management, LLC is the managing member of SR One Co-Invest Manager X, LLC. Simeon George is the managing member of SR One Capital Management, LLC. Each of SR One Co-Invest Manager X, LLC, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":666666,"source":{"system":"sec-edgar","filing":"0001209191-22-026258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000120919122026258/doc4.xml","form_type":"4"}},{"id":2287550,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T20:27:23.000Z","date":"2022-04-28","kind":"purchase","acquired":true,"shares":666667,"price":15,"value":10000005.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"SR One Co-Invest IX, LLC purchased 666,667 shares of common stock of the issuer in connection with the issuer's public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Co-Invest IX, LLC. SR One Co-Invest Manager IX, LLC is the managing member of SR One Co-Invest IX, LLC, and SR One Capital Management, LLC is the managing member of SR One Co-Invest Manager IX, LLC. Simeon George is the managing member of SR One Capital Management, LLC. Each of SR One Co-Invest Manager IX, LLC, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":666667,"source":{"system":"sec-edgar","filing":"0001209191-22-026258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595117/000120919122026258/doc4.xml","form_type":"4"}},{"id":2404526,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":2,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":3,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113514,"kind":"organization","name":"SR One Co-Invest II, LLC","position":4,"cik":"0001867644","reported_name":"SR One Co-Invest II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":5,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113515,"kind":"organization","name":"SR One Co-Invest II Manager, LLC","position":6,"cik":"0001910324","reported_name":"SR One Co-Invest II Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2022-02-10T13:41:09.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":433196,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by SR One Co-Invest II, LLC. SR One Co-Invest Manager II, LLC is the managing member of SR One Co-Invest II, LLC, and SR One Capital Management, LLC is the managing member of SR One Co-Invest Manager II, LLC.  Simeon George is the managing member of SR One Capital Management, LLC.  Each of SR One Co-Invest Manager II, LLC, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":433196},"source":{"system":"sec-edgar","filing":"0001209191-22-008281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919122008281/doc4.xml","form_type":"4"}},{"id":2404525,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":2,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":3,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113514,"kind":"organization","name":"SR One Co-Invest II, LLC","position":4,"cik":"0001867644","reported_name":"SR One Co-Invest II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":5,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113515,"kind":"organization","name":"SR One Co-Invest II Manager, LLC","position":6,"cik":"0001910324","reported_name":"SR One Co-Invest II Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2022-02-10T13:41:09.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":649795,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP.  Simeon George is the managing member of SR One Capital Management, LLC.  Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":649795},"source":{"system":"sec-edgar","filing":"0001209191-22-008281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919122008281/doc4.xml","form_type":"4"}},{"id":2404524,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":2,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":3,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113514,"kind":"organization","name":"SR One Co-Invest II, LLC","position":4,"cik":"0001867644","reported_name":"SR One Co-Invest II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":5,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113515,"kind":"organization","name":"SR One Co-Invest II Manager, LLC","position":6,"cik":"0001910324","reported_name":"SR One Co-Invest II Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2022-02-10T13:41:09.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":533389,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP.  Simeon George is the managing member of SR One Capital Management, LLC.  Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":533389},"source":{"system":"sec-edgar","filing":"0001209191-22-008281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919122008281/doc4.xml","form_type":"4"}},{"id":2404523,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":2,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":3,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113514,"kind":"organization","name":"SR One Co-Invest II, LLC","position":4,"cik":"0001867644","reported_name":"SR One Co-Invest II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":5,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113515,"kind":"organization","name":"SR One Co-Invest II Manager, LLC","position":6,"cik":"0001910324","reported_name":"SR One Co-Invest II Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2022-02-10T13:41:09.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":666651,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP.  Simeon George is the managing member of SR One Capital Management, LLC.  Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":666651},"source":{"system":"sec-edgar","filing":"0001209191-22-008281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919122008281/doc4.xml","form_type":"4"}},{"id":2404522,"issuer":{"id":15294,"kind":"organization","name":"Arcellx, Inc.","symbol":"ACLX"},"owners":[{"id":48340,"kind":"organization","name":"SR ONE CAPITAL MANAGEMENT, LLC","position":1,"cik":"0001853723","reported_name":"SR ONE CAPITAL MANAGEMENT, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107921,"kind":"organization","name":"SR ONE CAPITAL PARTNERS I, LP","position":2,"cik":"0001853724","reported_name":"SR ONE CAPITAL PARTNERS I, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":107920,"kind":"organization","name":"SR One Capital Fund I Aggregator LP","position":3,"cik":"0001848319","reported_name":"SR One Capital Fund I Aggregator LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113514,"kind":"organization","name":"SR One Co-Invest II, LLC","position":4,"cik":"0001867644","reported_name":"SR One Co-Invest II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39164,"kind":"person","name":"George Simeon","position":5,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":113515,"kind":"organization","name":"SR One Co-Invest II Manager, LLC","position":6,"cik":"0001910324","reported_name":"SR One Co-Invest II Manager, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2022-02-10T13:41:09.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":1550309,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock at the Reporting Person's election and automatically upon the closing of the initial public offering of Arcellx, Inc. (the \"Issuer\").  The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP.  Simeon George is the managing member of SR One Capital Management, LLC.  Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1550309},"source":{"system":"sec-edgar","filing":"0001209191-22-008281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1853723/000120919122008281/doc4.xml","form_type":"4"}}],"next_cursor":"2022-02-10T13:41:09.000000Z,2404522"}